-
公开(公告)号：EP1899270B1
公开(公告)日：2019-02-27
申请号：EP05753905.8
申请日：2005-06-21
-
2.发明公开ADSORBENS FÜR PHOSPHAT AUS WÄSSRIGEM MEDIUM, DESSEN HERSTELLUNG UND VERWENDUNG 失效吸附剂对磷酸根的水介质中，其生产和使用
公开(公告)号：EP0868125A1
公开(公告)日：1998-10-07
申请号：EP96944004.0
申请日：1996-12-19
发明人： GEISSER, Peter , PHILIPP, Erik
摘要： An adsorbent is proposed for phosphate from an aqueous medium, in particular for inorganic or nutrient-bound phosphate from body fluids or nutrients. The adsorbent contains polynuclear beta-iron hydroxide stabilised by carbohydrates and/or humic acid.
-
公开(公告)号：EP2111416B1
公开(公告)日：2019-05-15
申请号：EP08707897.8
申请日：2008-01-15
发明人： REIM, Stefan , GEISSER, Peter
-
4.发明授权WASSERLÖSLICHE EISEN-KOHLENHYDRATDERIVAT-KOMPLEXE, DEREN HERSTELLUNG UND DIESE ENTHALTENDE ARZNEIMITTEL 有权水溶性铁 - 碳水化合物复合物的衍生物，生产和药物含有它们的
公开(公告)号：EP2148890B1
公开(公告)日：2015-08-19
申请号：EP08759877.7
申请日：2008-05-21
IPC分类号： C08B31/18
CPC分类号： A61K31/295 , C08B31/00 , C08B31/18 , C08B31/185
-
公开(公告)号：EP2403506A1
公开(公告)日：2012-01-11
申请号：EP10705883.6
申请日：2010-03-01
发明人： WITZEL, Gisela , GEISSER, Peter , PHILIPP, Erik
CPC分类号： A61K33/06 , A61K33/10 , A61K33/26 , A61K2300/00
摘要： Subject of the present invention are compositions comprising a mixture of calcium, magnesium and iron salts for use as a pharmaceutical preparation for adsorbing phosphate, especially for use as pharmaceutical preparations for the treatment of hyperphosphataemia, chronic kidney deficiency as well as for the treatment of haemodialysis patients.
摘要翻译： 本发明的主题是包含钙盐，镁盐和铁盐的混合物的组合物，其用作吸附磷酸盐的药物制剂，特别是用作用于治疗高磷酸盐血症，慢性肾缺陷以及血液透析治疗的药物制剂 耐心。
-
6.发明授权FE(III)-2,4-DIOXO-1-CARBONYL-KOMPLEXVERBINDUNGEN ZUR VERWENDUNG BEI DER BEHANDLUNG UND DER PROPHYLAXE VON EISENMANGELERSCHEINUNGEN UND EISENMANGELANÄMIEN 有权FE（III）-2,4-二氧代-1-羰基络合物化合物，其用在治疗和预防缺铁出现和缺铁性贫血的
公开(公告)号：EP2714030B1
公开(公告)日：2015-08-12
申请号：EP12729036.9
申请日：2012-05-30
发明人： BARK, Thomas , BUHR, Wilm , BURCKHARDT, Susanna , BURGERT, Michael , CANCLINI, Camillo , DÜRRENBERGER, Franz , FUNK, Felix , GEISSER, Peter , KALOGERAKIS, Aris , MAYER, Simona , PHILIPP, Erik , REIM, Stefan , SIEBER, Diana , SCHMITT, Jörg , SCHWARZ, Katrin , KLOTZ, Jürgen
IPC分类号： A61K31/295 , A61K31/4453 , A61K31/5375 , A61P7/06
CPC分类号： A61K31/555 , A61K31/295 , A61K31/4453 , A61K31/5375 , A61K33/26 , A61K45/06 , C07F15/025
-
7.发明公开
公开(公告)号：EP1899270A2
公开(公告)日：2008-03-19
申请号：EP05753905.8
申请日：2005-06-21
IPC分类号： C01G49/06
CPC分类号： A61K33/26 , A23K20/30 , A23L33/16 , A23V2002/00 , B01J20/0229 , B01J20/06 , B01J2220/46 , C01G49/06 , C02F1/288 , C02F2101/105 , A23V2250/1592
摘要： The invention relates to a method for producing a novel composition and to the use of said composition as phosphate adsorbent, especially for administering said composition to humans and animals.
-
公开(公告)号：EP1848446A1
公开(公告)日：2007-10-31
申请号：EP06707742.0
申请日：2006-01-18
CPC分类号： A61K31/716 , A61K9/0019 , A61K31/295 , A61K33/26 , A61K47/26 , A61K47/61
摘要： The invention relates to novel therapeutic uses of iron(III) complex compounds with carbohydrates or derivatives thereof for producing a medicament that boosts immune defense and/or brain power.
-
9.发明授权ADSORBENS FÜR PHOSPHAT AUS WÄSSRIGEM MEDIUM, DESSEN HERSTELLUNG UND VERWENDUNG 失效吸附剂对磷酸根的水介质中，其生产和使用
公开(公告)号：EP0868125B1
公开(公告)日：2001-10-31
申请号：EP96944004.9
申请日：1996-12-19
发明人： GEISSER, Peter , PHILIPP, Erik
摘要： An adsorbent is proposed for phosphate from an aqueous medium, in particular for inorganic or nutrient-bound phosphate from body fluids or nutrients. The adsorbent contains polynuclear beta-iron hydroxide stabilised by carbohydrates and/or humic acid.
-
10.发明公开WASSERLÖSLICHE EISEN-KOHLENHYDRATDERIVAT-KOMPLEXE, DEREN HERSTELLUNG UND DIESE ENTHALTENDE ARZNEIMITTEL 有权水溶性铁 - 碳水化合物复合物的衍生物，生产和药物含有它们的
公开(公告)号：EP2148890A1
公开(公告)日：2010-02-03
申请号：EP08759877.7
申请日：2008-05-21
IPC分类号： C08B31/18
CPC分类号： A61K31/295 , C08B31/00 , C08B31/18 , C08B31/185
摘要： Water-soluble iron-carbohydrate derivative complex obtainable from an aqueous iron(III) salt solution and an aqueous solution of the product of the oxidation and subsequent derivatization of one or more maltodextrins with an aqueous hypochlorite solution at alkaline pH, wherein, in the case of use of a maltodextrin whose dextrose equivalent is from 5 to 20 and in the case of use of a mixture of a plurality of maltodextrins, the dextrose equivalent of the mixture is from 5 to 20 and the dextrose equivalent of each individual maltodextrin involved in the mixture is from 2 to 40, and the subsequent derivatization is effected with a suitable reagent, processes for preparing them and medicaments for treatment and prophylaxis of iron deficiency conditions.
-
-
-
-
-
-
-
-
-
搜索结果
18 条记录 (耗时 0.014 秒)
